CCM signaling complex (CSC) is a master regulator governing homeostasis of progestins and their mediated signaling cascades

We demonstrate that a novel signaling network among the CSC and mPRS is dynamically modulated and fine-tuned with intricate feedback regulations in PR negative cells, especially endothelial cells (ECs). Depletion of any of three CCMs (1, 2, 3) genes results in the disruption of non-classic mPRs-mediated signaling in-vitro as well as defective homeostasis of PRG in-vivo. Therefore, we propose the CSC is a master regulator of homeostasis of PRG and its associated classic and non-classic signaling cascades. Assisted with omic approaches, we identified signaling pathways involved and specific biomarkers associated with hemorrhagic events during CCM pathogenesis in-vitro and in-vivo. To our knowledge, this is the first report detailing etiology to predict the occurrence of early hemorrhagic events with a set of serum biomarkers.

[1]  Jun Zhang,et al.  CCM signaling complex (CSC) couples both classic and non-classic Progesterone receptor signaling , 2020, bioRxiv.

[2]  Jun Zhang,et al.  Emerging roles of CCM genes during tumorigenesis with potential application as novel biomarkers across major types of cancers , 2020, Oncology reports.

[3]  R. Shenkar,et al.  Novel hemorrhage models of cerebral cavernous malformations , 2020, bioRxiv.

[4]  A. Heredia,et al.  Novel Chronic Mouse Model of Cerebral Cavernous Malformations , 2020, Stroke.

[5]  Mark A. Smith,et al.  Comparative omics of CCM signaling complex (CSC) , 2020, Chinese Neurosurgical Journal.

[6]  S. Doré,et al.  Biomarker Application for Precision Medicine in Stroke , 2019, Translational Stroke Research.

[7]  Jun Zhang,et al.  Alternatively spliced isoforms reveal a novel type of PTB domain in CCM2 protein , 2019, Scientific Reports.

[8]  M. Fornage,et al.  Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke: A Meta-Analysis of Population-Based Studies Involving 17,180 Individuals. , 2019, Circulation research.

[9]  M. Corada,et al.  Endothelial cell clonal expansion in the development of cerebral cavernous malformations , 2019, Nature Communications.

[10]  R. Shenkar,et al.  Biomarkers of cavernous angioma with symptomatic hemorrhage. , 2019, JCI insight.

[11]  Jun Zhang,et al.  Systems-wide analysis unravels the new roles of CCM signal complex (CSC) , 2019, bioRxiv.

[12]  B. Fiebich,et al.  Lipopolysaccharide-Induced Neuroinflammation as a Bridge to Understand Neurodegeneration , 2019, International journal of molecular sciences.

[13]  Ming Liu,et al.  Serum Albumin Is Negatively Associated with Hemorrhagic Transformation in Acute Ischemic Stroke Patients , 2019, Cerebrovascular Diseases.

[14]  I. Awad,et al.  Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice. , 2019, Blood.

[15]  Wei Zhang,et al.  Serum lipoprotein(a) and risk of hemorrhagic stroke among incident peritoneal dialysis patients: a large study from a single center in China , 2019, Renal failure.

[16]  B. Ford,et al.  Identification of novel blood biomarker panels to detect ischemic stroke in patients and their responsiveness to therapeutic intervention , 2018, Brain Research.

[17]  Zhongjun Liu,et al.  Progression of aggressive vertebral hemangiomas during pregnancy , 2018, Medicine.

[18]  D. Marchuk,et al.  Cerebral Cavernous Malformations Develop through Clonal Expansion of Mutant Endothelial Cells , 2018, bioRxiv.

[19]  Jun Zhang,et al.  Recent advances in cerebral cavernous malformation research , 2018, Vessel plus.

[20]  Taura L. Barr,et al.  High-throughput profiling of the circulating proteome suggests sexually dimorphic corticosteroid signaling following ischemic stroke. , 2018, Physiological genomics.

[21]  Maria Chondrogianni,et al.  Blood biomarkers in ischemic stroke: potential role and challenges in clinical practice and research , 2018, Critical reviews in clinical laboratory sciences.

[22]  Y. Mukouyama,et al.  Whole-mount Confocal Microscopy for Adult Ear Skin: A Model System to Study Neuro-vascular Branching Morphogenesis and Immune Cell Distribution. , 2018, Journal of visualized experiments : JoVE.

[23]  S. O'Mahony,et al.  Steroids, stress and the gut microbiome‐brain axis , 2018, Journal of neuroendocrinology.

[24]  Dean Y. Li,et al.  Plasma Biomarkers of Inflammation Reflect Seizures and Hemorrhagic Activity of Cerebral Cavernous Malformations , 2018, Translational Stroke Research.

[25]  D. Cistola,et al.  Novel functions of CCM1 delimit the relationship of PTB/PH domains. , 2017, Biochimica et biophysica acta. Proteins and proteomics.

[26]  Luis Cano,et al.  Blood Biomarkers for the Early Diagnosis of Stroke: The Stroke-Chip Study , 2017, Stroke.

[27]  X. Ji,et al.  Low Serum Albumin level as a Predictor of Hemorrhage Transformation after Intravenous Thrombolysis in Ischemic Stroke Patients , 2017, Scientific Reports.

[28]  L. Nigro,et al.  Vertebral hemangiomas: common lesions with still many unknown aspects. , 2017, Journal of spine surgery.

[29]  Jin-Ju Jeong,et al.  Gastrointestinal inflammation by gut microbiota disturbance induces memory impairment in mice , 2017, Mucosal Immunology.

[30]  Dean Y. Li,et al.  Endothelial TLR4 and the microbiome drive cerebral cavernous malformations , 2017, Nature.

[31]  Tatsuhide Tanaka,et al.  Changes in endothelial cell proliferation and vascular permeability after systemic lipopolysaccharide administration in the subfornical organ , 2016, Journal of Neuroimmunology.

[32]  Pei-Xi Wang,et al.  Serum albumin level is associated with the recurrence of acute ischemic stroke. , 2016, The American journal of emergency medicine.

[33]  F. Bonier,et al.  Evolutionary Endocrinology: Hormones as Mediators of Evolutionary Phenomena: An Introduction to the Symposium. , 2016, Integrative and comparative biology.

[34]  D. Stein,et al.  Neuroprotection by progesterone after transient cerebral ischemia in stroke-prone spontaneously hypertensive rats , 2016, Hormones and Behavior.

[35]  Md. Babul Hossain,et al.  Establishment of procedures for studying mPR-interacting agents and physiological roles of mPR , 2016, Steroids.

[36]  M. Schumacher,et al.  Progesterone neuroprotection: The background of clinical trial failure , 2016, The Journal of Steroid Biochemistry and Molecular Biology.

[37]  K. Rejdak,et al.  Worse Neurological State During Acute Ischemic Stroke is Associated with a Decrease in Serum Albumin Levels , 2016, Journal of Molecular Neuroscience.

[38]  A. Birukova,et al.  Role of Krev Interaction Trapped-1 in Prostacyclin-Induced Protection against Lung Vascular Permeability Induced by Excessive Mechanical Forces and Thrombin Receptor Activating Peptide 6. , 2015, American journal of respiratory cell and molecular biology.

[39]  W. Banks,et al.  Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit , 2015, Journal of Neuroinflammation.

[40]  X. Jin,et al.  Association between the interleukin-6-174 G/C polymorphism and risk of ischemic stroke: a meta-analysis. , 2015, Genetics and molecular research : GMR.

[41]  K. Bortoluci,et al.  Revisiting Mouse Peritoneal Macrophages: Heterogeneity, Development, and Function , 2015, Front. Immunol..

[42]  F. Sharp,et al.  Biomarker Panels in Ischemic Stroke , 2015, Stroke.

[43]  R. Sauve,et al.  Hormonal Contraceptives and Cerebral Venous Thrombosis Risk: A Systematic Review and Meta-Analysis , 2015, Front. Neurol..

[44]  A. Mota-Pinto,et al.  Membrane progesterone receptors in human regulatory T cells: a reality in pregnancy , 2015, BJOG : an international journal of obstetrics and gynaecology.

[45]  F. Klawonn,et al.  Lipopolysaccharide binding protein, interleukin-10, interleukin-6 and C-reactive protein blood levels in acute ischemic stroke patients with post-stroke infection , 2015, Journal of Neuroinflammation.

[46]  C. Sudlow,et al.  Prognostic value of blood interleukin-6 in the prediction of functional outcome after stroke: A systematic review and meta-analysis , 2014, Journal of Neuroimmunology.

[47]  F. Tomasello,et al.  Thoracic spinal cord cavernous angioma: a case report and review of the literature , 2014, Journal of Medical Case Reports.

[48]  J. Cazareth,et al.  Molecular and cellular neuroinflammatory status of mouse brain after systemic lipopolysaccharide challenge: importance of CCR2/CCL2 signaling , 2014, Journal of Neuroinflammation.

[49]  S. Jayi,et al.  An aggressive vertebral hemangioma in pregnancy: a case report , 2014, Journal of Medical Case Reports.

[50]  F. Ghafoor,et al.  TNF-alpha: a risk factor for ischemic stroke. , 2014, Journal of Ayub Medical College, Abbottabad : JAMC.

[51]  R. Medzhitov,et al.  Tissue-Specific Signals Control Reversible Program of Localization and Functional Polarization of Macrophages , 2014, Cell.

[52]  D. Stein,et al.  Progesterone Attenuates Hemorrhagic Transformation after Delayed tPA Treatment in an Experimental Model of Stroke in Rats: Involvement of the VEGF–MMP Pathway , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[53]  I. Nakagawa,et al.  Cavernous malformations in pregnancy. , 2013, Neurologia medico-chirurgica.

[54]  D. Brewer,et al.  Novel progesterone receptors: neural localization and possible functions , 2013, Front. Neurosci..

[55]  A. Munshi,et al.  Serum albumin levels in ischemic stroke and its subtypes: correlation with clinical outcome. , 2013, Nutrition.

[56]  C. Bagley,et al.  Spinal Cavernous and Capillary Hemangiomas in Adults , 2013, Spine.

[57]  Meharvan Singh,et al.  Progesterone and neuroprotection , 2013, Hormones and Behavior.

[58]  R. Hui,et al.  Polymorphism of tumor necrosis factor alpha (TNF-alpha) gene promoter, circulating TNF-alpha level, and cardiovascular risk factor for ischemic stroke , 2012, Journal of Neuroinflammation.

[59]  C. Woernle,et al.  Neurosurgical considerations on highly eloquent brainstem cavernomas during pregnancy , 2012, Clinical Neurology and Neurosurgery.

[60]  A. Abou-Hamden,et al.  Cerebral Cavernous Malformations and Pregnancy: Hemorrhage Risk and Influence on Obstetrical Management. , 2012, Neurosurgery.

[61]  Jeremy Seto,et al.  Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease. , 2012, The Journal of clinical investigation.

[62]  K. Lambertsen,et al.  Inflammatory Cytokines in Experimental and Human Stroke , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[63]  A. Jansson,et al.  Progesterone and levonorgestrel regulate expression of 17βHSD-enzymes in progesterone receptor positive breast cancer cell line T47D. , 2012, Biochemical and biophysical research communications.

[64]  P. Thomas,et al.  Characterization of multiple membrane progestin receptor (mPR) subtypes from the goldfish ovary and their roles in the induction of oocyte maturation. , 2012, General and comparative endocrinology.

[65]  Li Chen,et al.  [Prognostic effects of serum albumin level in patients with progressive stroke]. , 2012, Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue.

[66]  G. Jickling,et al.  Blood Biomarkers in Stroke: Research and Clinical Practice , 2012, International journal of stroke : official journal of the International Stroke Society.

[67]  E. Ghosn,et al.  Cellular Renewal and Improvement of Local Cell Effector Activity in Peritoneal Cavity in Response to Infectious Stimuli , 2011, PloS one.

[68]  A. Day,et al.  The natural history of intracranial cavernous malformations. , 2011, Neurosurgical focus.

[69]  C. Lange,et al.  Membrane progesterone receptor expression in mammalian tissues: A review of regulation and physiological implications , 2011, Steroids.

[70]  R. Kucherlapati,et al.  A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease. , 2011, Human molecular genetics.

[71]  D. Rigamonti,et al.  Ccm1 Regulates Microvascular Morphogenesis during Angiogenesis , 2010, Journal of Vascular Research.

[72]  Wei Li,et al.  Progesterone reverses the mesenchymal phenotypes of basal phenotype breast cancer cells via a membrane progesterone receptor mediated pathway , 2010, Breast Cancer Research.

[73]  D. Rigamonti,et al.  Ccm1 Assures Microvascular Integrity During Angiogenesis , 2010, Translational Stroke Research.

[74]  Leonore A. Herzenberg,et al.  Two physically, functionally, and developmentally distinct peritoneal macrophage subsets , 2010, Proceedings of the National Academy of Sciences.

[75]  B. Kandemir,et al.  There are no estrogen and progesterone receptors in cerebral cavernomas: a preliminary immunohistochemical study. , 2009, Surgical neurology.

[76]  K. Furie,et al.  Molecular biomarkers in stroke diagnosis and prognosis. , 2009, Biomarkers in medicine.

[77]  E. Chien,et al.  Mifepristone acts as progesterone antagonist of non-genomic responses but inhibits phytohemagglutinin-induced proliferation in human T cells. , 2009, Human reproduction.

[78]  M. Schumacher,et al.  Progesterone neuroprotection in traumatic CNS injury and motoneuron degeneration , 2009, Frontiers in Neuroendocrinology.

[79]  J. Brøgger,et al.  Serum Albumin in Ischemic Stroke Patients: The Higher the Better , 2009, Cerebrovascular Diseases.

[80]  N. Petit,et al.  Tissue-specific conditional CCM2 knockout mice establish the essential role of endothelial CCM2 in angiogenesis: implications for human cerebral cavernous malformations , 2009, Disease Models & Mechanisms.

[81]  G. Steinberg,et al.  Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. , 2009, Human molecular genetics.

[82]  U. Felbor,et al.  A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells , 2008, Human molecular genetics.

[83]  H. Dietz,et al.  KRIT1 MODULATES β1‐INTEGRIN‐MEDIATED ENDOTHELIAL CELL PROLIFERATION , 2008, Neurosurgery.

[84]  R. Busto,et al.  Albumin Therapy Augments the Effect of Thrombolysis on Local Vascular Dynamics in a Rat Model of Arteriolar Thrombosis: A Two-Photon Laser-Scanning Microscopy Study , 2008, Stroke.

[85]  M. Ginsberg,et al.  Albumin Therapy Improves Local Vascular Dynamics in a Rat Model of Primary Microvascular Thrombosis: A Two-Photon Laser-Scanning Microscopy Study , 2008, Stroke.

[86]  L. Giudice,et al.  Expression of membrane progesterone receptors on human T lymphocytes and Jurkat cells and activation of G-proteins by progesterone. , 2007, The Journal of endocrinology.

[87]  C. Moy,et al.  The Albumin in Acute Stroke Trial (ALIAS); Design and Methodology , 2007, International journal of stroke : official journal of the International Stroke Society.

[88]  M. Cahill Progesterone receptor membrane component 1: An integrative review , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[89]  H. Dietz,et al.  INTERACTION BETWEEN KRIT1 AND MALCAVERNIN: IMPLICATIONS FOR THE PATHOGENESIS OF CEREBRAL CAVERNOUS MALFORMATIONS , 2007, Neurosurgery.

[90]  J. Dong,et al.  Steroid and G protein binding characteristics of the seatrout and human progestin membrane receptor alpha subtypes and their evolutionary origins. , 2007, Endocrinology.

[91]  Ching-Pang Chang,et al.  Non‐genomic immunosuppressive actions of progesterone inhibits PHA‐induced alkalinization and activation in T cells , 2006, Journal of cellular biochemistry.

[92]  M. Szczepanik Interplay between Helicobacter pylori and the immune system. Clinical implications. , 2006, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[93]  M. Ginsberg,et al.  The ALIAS Pilot Trial: A Dose-Escalation and Safety Study of Albumin Therapy for Acute Ischemic Stroke—II: Neurologic Outcome and Efficacy Analysis , 2006, Stroke.

[94]  M. Ginsberg,et al.  The ALIAS Pilot Trial: A Dose-Escalation and Safety Study of Albumin Therapy for Acute Ischemic Stroke—I: Physiological Responses and Safety Results , 2006, Stroke.

[95]  R. Spetzler,et al.  Hemorrhage of cavernous malformations during pregnancy and in the peripartum period: causal or coincidence? Case report and review of the literature. , 2006, Neurosurgical focus.

[96]  A. Cohen-Gadol,et al.  Coexistence of intracranial and spinal cavernous malformations: a study of prevalence and natural history. , 2006, Journal of neurosurgery.

[97]  H. Matsunami,et al.  Neuronal expression of the Ccm2 gene in a new mouse model of cerebral cavernous malformations , 2006, Mammalian Genome.

[98]  H. Augustin,et al.  Angiopoietin-2 sensitizes endothelial cells to TNF-α and has a crucial role in the induction of inflammation , 2006, Nature Medicine.

[99]  S. Tomten,et al.  Serum albumin and self-reported prevalence of stroke: a population-based, cross-sectional study: , 2006 .

[100]  S. Tomten,et al.  Serum albumin and self-reported prevalence of stroke: a population-based, cross-sectional study , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[101]  J. Greenwood,et al.  Blood‐brain barrier‐specific properties of a human adult brain endothelial cell line , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[102]  C. Josenhans,et al.  Helicobacter pylori and the innate immune system. , 2005, International journal of medical microbiology : IJMM.

[103]  E. Younglai,et al.  Non-genomic action of estradiol and progesterone on cytosolic calcium concentrations in primary cultures of human granulosa-lutein cells. , 2005, Human reproduction.

[104]  T. Ishibashi,et al.  Progesterone receptor subtypes in vascular smooth muscle cells of human aorta. , 2005, Endocrine journal.

[105]  T. Simoncini,et al.  Differential signal transduction of progesterone and medroxyprogesterone acetate in human endothelial cells. , 2004, Endocrinology.

[106]  D. Edwards,et al.  Receptor mechanisms of rapid extranuclear signalling initiated by steroid hormones. , 2004, Essays in biochemistry.

[107]  A. Słowik,et al.  Serum Albumin Level as a Predictor of Ischemic Stroke Outcome , 2004, Stroke.

[108]  Dean Y. Li,et al.  Ccm1 is required for arterial morphogenesis: implications for the etiology of human cavernous malformations , 2004, Development.

[109]  P. Whincup,et al.  Serum albumin and risk of stroke, coronary heart disease, and mortality: the role of cigarette smoking. , 2004, Journal of clinical epidemiology.

[110]  F. Meyer,et al.  Successful brainstem cavernous malformation resection after repeated hemorrhages during pregnancy. , 2003, Surgical neurology.

[111]  R. Aebersold,et al.  A statistical model for identifying proteins by tandem mass spectrometry. , 2003, Analytical chemistry.

[112]  P. Thomas,et al.  Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[113]  Alexey I Nesvizhskii,et al.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. , 2002, Analytical chemistry.

[114]  B. White,et al.  Membrane-Initiated Events Account for Progesterone's Ability to Regulate Intracellular Free Calcium Levels and Inhibit Rat Granulosa Cell Mitosis1 , 2002, Biology of reproduction.

[115]  D. Chang,et al.  Interaction between krit1 and icap1alpha infers perturbation of integrin beta1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation. , 2001, Human molecular genetics.

[116]  B. Crain,et al.  Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations , 2001, Journal of neurology, neurosurgery, and psychiatry.

[117]  R. Busto,et al.  Human Albumin Therapy of Acute Ischemic Stroke: Marked Neuroprotective Efficacy at Moderate Doses and With a Broad Therapeutic Window , 2001, Stroke.

[118]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[119]  L. di Tommaso,et al.  Progesterone receptor expression in orbital cavernous hemangiomas , 2000, Virchows Archiv.

[120]  Crone,et al.  The natural history of cavernous malformations: a prospective study of 68 patients , 1999, Neurosurgery.

[121]  E. I. Slin'ko,et al.  Vertebral hemangiomas: diagnosis, management, natural history and clinicopathological correlates in 86 patients. , 1998, Surgical neurology.

[122]  B. O’Malley,et al.  Mutual and intercompartmental regulation of estrogen receptor and progesterone receptor expression in the mouse uterus. , 1998, Biology of reproduction.

[123]  R. Spetzler,et al.  De novo formation of a central nervous system cavernous malformation: implications for predicting risk of hemorrhage. Case report and review of the literature. , 1997, Journal of neurosurgery.

[124]  W. Harper,et al.  Cerebral cavernous malformations: natural history and prognosis after clinical deterioration with or without hemorrhage. , 1997, Journal of neurosurgery.

[125]  A. Awada,et al.  Cavernous Angioma Presenting as Pregnancy‐Related Seizures , 1997, Epilepsia.

[126]  F. Giangaspero,et al.  Growth, subsequent bleeding, and de novo appearance of cerebral cavernous angiomas. , 1996, Neurosurgery.

[127]  D. Kondziolka,et al.  The natural history of cerebral cavernous malformations. , 1995, Journal of neurosurgery.

[128]  Geoffrey L. Hammond,et al.  Potential functions of plasma steroid-binding proteins , 1995, Trends in Endocrinology & Metabolism.

[129]  I. Awad,et al.  Intracranial cavernous malformations: lesion behavior and management strategies. , 1995, Neurosurgery.

[130]  S. Kameyama,et al.  Natural history of intracranial cavernous malformations. , 1995, Journal of neurosurgery.

[131]  R. Gillum,et al.  Relation between serum albumin concentration and stroke incidence and death: the NHANES I Epidemiologic Follow-up Study. , 1994, American journal of epidemiology.

[132]  S. Canavero Intramedullary cavernous angiomas of the spinal cord: clinical presentation, pathological features, and surgical management. , 1993, Neurosurgery.

[133]  D. Louis,et al.  Intramedullary cavernous angiomas of the spinal cord: clinical presentation, pathological features, and surgical management. , 1992, Neurosurgery.

[134]  John R. Robinson,et al.  Natural history of the cavernous angioma. , 1991, Journal of neurosurgery.

[135]  A. Elster,et al.  An analysis of the natural history of cavernous angiomas. , 1991, Journal of neurosurgery.

[136]  G. Chaouat,et al.  Progesterone Suppression of Pregnancy Lymphocytes Is not Mediated by Glucocorticoid Effect , 1990, American journal of reproductive immunology.

[137]  P Chambon,et al.  Two distinct estrogen‐regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. , 1990, The EMBO journal.

[138]  H. Handa,et al.  Intracranial and orbital cavernous angiomas. A review of 30 cases. , 1986, Journal of neurosurgery.

[139]  J. Kato,et al.  [Introduction to obstetrical endocrinology. 23. Sex differentiation and hormones]. , 1985, Josanpu zasshi = The Japanese journal for midwife.

[140]  L. Andersson,et al.  Binding of progestins to the glucocorticoid receptor. Correlation to their glucocorticoid-like effects on in vitro functions of human mononuclear leukocytes. , 1983, Biochemical pharmacology.

[141]  M. Feinsod,et al.  ORBITAL HEMANGIOMA GROWTH DURING PREGNANCY , 1970, Acta ophthalmologica.

[142]  W. Walker Methods to Study the Innate Immune Response to Sepsis. , 2018, Methods in molecular biology.

[143]  Jun Guo,et al.  Serum albumin: a risk of stroke? , 2017, The American journal of emergency medicine.

[144]  Yun-Tao Zhao,et al.  An unusual etiology for acquired long QT syndrome and torsade de pointes. , 2017, The American journal of emergency medicine.

[145]  P. Thomas,et al.  Characterization, neurosteroid binding and brain distribution of human membrane progesterone receptors δ and {epsilon} (mPRδ and mPR{epsilon}) and mPRδ involvement in neurosteroid inhibition of apoptosis. , 2013, Endocrinology.

[146]  M. Kalani,et al.  Risk for symptomatic hemorrhage of cerebral cavernous malformations during pregnancy. , 2013, Journal of neurosurgery.

[147]  A. Demchuk,et al.  Presence of DWI lesion an acute MRI in minor stroke and TIA patients predicts recurrent stroke and clinical outcome , 2005 .

[148]  M. Byrne,et al.  Is the host responsible? -- the role of the immune system in Helicobacter pylori infection. , 2004, Medical hypotheses.

[149]  P. Saunders,et al.  Steroid receptor expression in uterine natural killer cells. , 2003, The Journal of clinical endocrinology and metabolism.

[150]  R. Gillum,et al.  Assessment of serum albumin concentration as a risk factor for stroke and coronary disease in African Americans and whites. , 2000, Journal of the National Medical Association.

[151]  T. Schwartz,et al.  Estrogen and progesterone receptor-negative T11 vertebral hemangioma presenting as a postpartum compression fracture: case report and management. , 2000, Neurosurgery.

[152]  M. Lawton,et al.  Cavernous malformations of the brainstem: experience with 100 patients. , 1999, Journal of neurosurgery.

[153]  P. Giangrande,et al.  The A and B isoforms of the human progesterone receptor: two functionally different transcription factors encoded by a single gene. , 1999, Recent progress in hormone research.

[154]  E. Roth,et al.  Serum albumin level as a predictor of geriatric stroke rehabilitation outcome. , 1994, Archives of physical medicine and rehabilitation.

[155]  T. Yamamoto,et al.  Surgical management of cavernous malformations of the third ventricle. , 1994, Journal of neurosurgery.

[156]  M. W. Fox,et al.  The natural history and management of symptomatic and asymptomatic vertebral hemangiomas. , 1993, Journal of neurosurgery.

[157]  G. Pinto,et al.  Cavernous angioma of the spinal dura. , 1991, Journal of neurosurgical sciences.